Boris A Reva, PhD
img_Boris A Reva
ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
Publications

Selected Publications

Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: Modulating the cold tumor microenvironment. Sujit S. Nair, Dimple Chakravarty, Sreekumar Balan, Alexander Hakansson, Manuel Duval, Elai Davicioni, Yang Liu, Swati Bhardwaj, Tin Htwe Thin, Monica Garcia-Barros, Kenneth Haines, Majd Al Shaarani, Rachel Weil, Marcia Meseck, Parita Ratnani, Monali Fatterpekar, Elena Gonzalez-Gugel, Adam Farkas, Vinayak Wagaskar, Ivan Jambor, Kacie Schlussel, Cristina Pasat-karasik, Kamala Bhatt, Zachary Dovey, Adriana Pedraza, Akriti Gupta, Dara Lundon, Ante Peros, Sneha Parekh, Lily Davenport, Xiangfu Zhang, Raghav Gupta, Macy Robison, Cynthia Knauer, Ethan Ellis, Dmitry Rykunov, Boris Reva, Babu Padanilam, Matthew D. Galsky, Rachel Brody, Mani Menon, Andres M. Salazar, Nina Bhardwaj, Ashutosh K. Tewari. Med

Sympathetic axonogenesis promotes adenoid cystic carcinoma progression. Chun Hao Chen, Boris Reva, Nora Katabi, Avishai Wizel, Hongbo Xu, Alan L. Ho, Luc G.T. Morris, Richard L. Bakst, Anuraag S. Parikh, Yotam Drier, Sylvie Deborde, Richard J. Wong. Journal of Experimental Medicine

Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets. Iga Kołodziejczak-Guglas, Renan L.S. Simões, Emerson de Souza Santos, Elizabeth G. Demicco, Rossana N. Lazcano Segura, Weiping Ma, Pei Wang, Yifat Geffen, Erik Storrs, Francesca Petralia, Antonio Colaprico, Felipe da Veiga Leprevost, Pietro Pugliese, Michele Ceccarelli, Houtan Noushmehr, Alexey I. Nesvizhskii, Bożena Kamińska, Waldemar Priebe, Jan Lubiński, Bing Zhang, Alexander J. Lazar, Paweł Kurzawa, Mehdi Mesri, Ana I. Robles, Alicia Francis, Amanda G. Paulovich, Anna P. Calinawan, Antonio Iavarone, Arul M. Chinnaiyan, Bo Wen, Boris Reva, Brian J. Druker, Caleb M. Lindgren, Chandan Kumar-Sinha, Chelsea J. Newton, Chen Huang, Chet Birger, Corbin Day, D. R. Mani, Daniel Cui Zhou, Daniel W. Chan, David Fenyö, David I. Heiman, Dmitry Rykunov, Emily Huntsman, Eric E. Schadt, Eric J. Jaehnig, Eunkyung An, Shrabanti Chowdhury, Zeynep H. Gümüş. Cell Genomics

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Reva during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Tymora-analytics

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.